PubMed

Summaries for patients. Blood pressure drugs and heart failure.

[No authors listed]

Ann Intern Med. 2002 Sep 3;137(5 Part 1):I38. No abstract available. PMID: 12204046 [PubMed - indexed for MEDLINE]Related articlesFree article

Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial.

Davis BR, Cutler JA, Furberg CD, Wright JT, Farber MA, Felicetta JV, Stokes JD; ALLHAT Collaborative Research Group.

Ann Intern Med. 2002 Sep 3;137(5 Part 1):313-20.PMID: 12204014 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study.

Barzilay JI, Davis BR, Bettencourt J, Margolis KL, Goff DC Jr, Black H, Habib G, Ellsworth A, Force RW, Wiegmann T, Ciocon JO, Basile JN; ALLHAT Collaborative Research Group.

J Clin Hypertens (Greenwich). 2004 Mar;6(3):116-25.PMID: 15010644 [PubMed - indexed for MEDLINE]Related articles

[ALLHAT: Old Hat Hits All? On selection of the optimal antihypertensive drug]

Slany J.

Wien Klin Wochenschr. 2003 Mar 31;115(5-6):149-51. German. No abstract available. PMID: 12741071 [PubMed - indexed for MEDLINE]Related articles

Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

Hypertension. 2003 Sep;42(3):239-46. Epub 2003 Aug 18.PMID: 12925554 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, Goff D, Leenen F, Mohiuddin S, Papademetriou V, Proschan M, Ellsworth A, Golden J, Colon P, Crow R; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

Circulation. 2006 May 9;113(18):2201-10. Epub 2006 May 1.PMID: 16651474 [PubMed - indexed for MEDLINE]Related articlesFree article

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, Black HR, Hamilton BP, Holland J, Nwachuku C, Papademetriou V, Probstfield J, Wright JT Jr, Alderman MH, Weiss RJ, Piller L, Bettencourt J, Walsh SM; ALLHAT Collaborative Research Group.

J Clin Hypertens (Greenwich). 2002 Nov-Dec;4(6):393-404.PMID: 12461301 [PubMed - indexed for MEDLINE]Related articles

The ALLHAT Trial. Diuretics are still the preferred initial drugs for high blood pressure.

Vidt DG.

Cleve Clin J Med. 2003 Mar;70(3):263-9.PMID: 12678218 [PubMed - indexed for MEDLINE]Related articlesFree article

Antihypertensive therapy, the alpha-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study.

Davis BR, Arnett DK, Boerwinkle E, Ford CE, Leiendecker-Foster C, Miller MB, Black H, Eckfeldt JH.

Pharmacogenomics J. 2007 Apr;7(2):112-22. Epub 2006 May 16.PMID: 16702981 [PubMed - indexed for MEDLINE]Related articles

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Wright JT Jr, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, Basile JN, Black HR, Dart R, Gupta AK, Hamilton BP, Einhorn PT, Haywood LJ, Jafri SZ, Louis GT, Whelton PK, Scott CL, Simmons DL, Stanford C, Davis BR.

Arch Intern Med. 2008 Jan 28;168(2):207-17.PMID: 18227370 [PubMed - indexed for MEDLINE]Related articlesFree article

Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.

Payeras AC, Sladek K, Lembo G, Alberici M.

Clin Drug Investig. 2007;27(9):623-32.PMID: 17705571 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. Do the effects of blood pressure drugs differ by kidney function?

[No authors listed]

Ann Intern Med. 2006 Feb 7;144(3):I33. No abstract available. PMID: 16461958 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.

Chapman N, Chang CL, Dahlöf B, Sever PS, Wedel H, Poulter NR; ASCOT Investigators.

Circulation. 2008 Jul 1;118(1):42-8. Epub 2008 Jun 16.PMID: 18559700 [PubMed - indexed for MEDLINE]Related articlesFree article

Preventing vascular events due to elevated blood pressure.

Yusuf S.

Circulation. 2006 May 9;113(18):2166-8. No abstract available. PMID: 16684871 [PubMed - indexed for MEDLINE]Related articlesFree article

How effective is doxazosin compared with chlorthalidone in the treatment of hypertension?

Koval PG, McDiarmid T.

J Fam Pract. 2000 Jul;49(7):597-8. No abstract available. PMID: 10923564 [PubMed - indexed for MEDLINE]Related articles

Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study.

Arnett DK, Davis BR, Ford CE, Boerwinkle E, Leiendecker-Foster C, Miller MB, Black H, Eckfeldt JH.

Circulation. 2005 Jun 28;111(25):3374-83. Epub 2005 Jun 20.PMID: 15967849 [PubMed - indexed for MEDLINE]Related articlesFree article

The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy.

Julius S, Weber MA, Kjeldsen SE, McInnes GT, Zanchetti A, Brunner HR, Laragh J, Schork MA, Hua TA, Amerena J, Balazovjech I, Cassel G, Herczeg B, Koylan N, Magometschnigg D, Majahalme S, Martinez F, Oigman W, Seabra Gomes R, Zhu JR.

Hypertension. 2006 Sep;48(3):385-91. Epub 2006 Jul 24.PMID: 16864741 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study.

de Alvaro F, Hernández-Presa MA; ASOCIA Study.

J Cardiovasc Pharmacol. 2006 Feb;47(2):271-6.PMID: 16495766 [PubMed - indexed for MEDLINE]Related articles

Doxazosin in the current treatment of hypertension.

Wykretowicz A, Guzik P, Wysocki H.

Expert Opin Pharmacother. 2008 Mar;9(4):625-33. Review.PMID: 18312163 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.

Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber MA, Franklin S, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T; ALLHAT Collaborative Research Group.

Ann Intern Med. 2006 Feb 7;144(3):172-80.PMID: 16461961 [PubMed - indexed for MEDLINE]Related articlesFree article